Dursun, Serdar M.

Glutamate and the Neural Basis of the Subjective Effects of Ketamine: A Pharmaco–Magnetic Resonance Imaging Study

Deakin, J. F. W., Lees, J., McKie, S., Hallak, J. E. C., Williams, S. R., & Dursun, S. M. (2008) · Archives of General Psychiatry

Treatment of Major DepressionPsychedelics and Drug Studies

Cited by 311

Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers

Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 209

Cannabidiol monotherapy for treatment-resistant schizophrenia

Zuardi, A. W., Hallak, J. E. C., Dursun, S. M., Morais, S. L., Sanches, R. F., Musty, R. E., & Crippa, J. A. S. (2006) · Journal of Psychopharmacology

Cannabis and Cannabinoid ResearchSchizophrenia research and treatment

Cited by 192

ADHD-200 Global Competition: diagnosing ADHD using personal characteristic data can outperform resting state fMRI measurements

Brown, M. R. G., Sidhu, G. S., Greiner, R., Asgarian, N., Bastani, M., Silverstone, P. H., Greenshaw, A. J., & Dursun, S. M. (2012) · Frontiers in Systems Neuroscience

Attention Deficit Hyperactivity DisorderFunctional Brain Connectivity Studies

Cited by 185

Esketamine for treatment resistant depression

Swainson, J., Thomas, R. K., Archer, S., Chrenek, C., MacKay, M.-A., Baker, G., Dursun, S., Klassen, L. J., Chokka, P., & Demas, M. L. (2019) · Expert Review of Neurotherapeutics

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 151

Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation

Briggs, A., Wild, D., Lees, M., Reaney, M., Dursun, S., Parry, D., & Mukherjee, J. (2008) · Health and Quality of Life Outcomes

Health Systems, Economic Evaluations, Quality of LifeSchizophrenia research and treatment

Cited by 122

The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects

Hallak, J. E. C., Dursun, S. M., Bosi, D. C., de Macedo, L. R. H., Machado-de-Sousa, J. P., Abrão, J., Crippa, J. A. S., McGuire, P., Krystal, J. H., Baker, G. B., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Cannabis and Cannabinoid ResearchPsychedelics and Drug Studies

Cited by 83

Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania

Valvassori, S. S., Elias, G., de Souza, B., Petronilho, F., Dal-Pizzol, F., Kapczinski, F., Trzesniak, C., Tumas, V., Dursun, S., Nisihara Chagas, M. H., et al. (2011) · Journal of Psychopharmacology

Cannabis and Cannabinoid ResearchBipolar Disorder and Treatment

Cited by 80

Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness

Thomas, R. K., Baker, G., Lind, J., & Dursun, S. (2018) · Journal of Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 69

Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research

Dursun, S. M., & Kutcher, S. (1999) · Medical Hypotheses

Smoking Behavior and CessationNicotinic Acetylcholine Receptors Study

Cited by 67

A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis

Fallon, P., & Dursun, S. M. (2011) · Journal of Psychopharmacology

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 56

Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action

dos Santos, R. G., Hallak, J. E., Baker, G., & Dursun, S. (2021) · Journal of Psychopharmacology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 55

Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients

Fallon, P., Dursun, S., & Deakin, B. (2012) · Therapeutic Advances in Psychopharmacology

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 47

Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia

Chaves, C., Marque, C. R., Maia-de-Oliveira, J. P., Wichert-Ana, L., Ferrari, T. B., Santos, A. C., Araújo, D., Machado-de-Sousa, J. P., Bressan, R. A., Elkis, H., et al. (2015) · Schizophrenia Research

Schizophrenia research and treatmentTryptophan and brain disorders

Cited by 41

Antidepressant discontinuation (withdrawal) symptoms presenting as ‘stroke’

Haddad, P. M., Devarajan, S., & Dursun, S. M. (2001) · Journal of Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 25